Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children
Jorge A. Soto, Felipe Melo-González, Cristián Gutiérrez-Vera, et al.
mBio (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 20

Showing 20 citing articles:

Pathophysiological, immunological, and inflammatory features of long COVID
Karen Böhmwald, Benjamín Diethelm‐Varela, Linmar Rodríguez-Guilarte, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 21
Real-world effectiveness of primary series and booster doses of inactivated COVID-19 vaccine against Omicron BA.2 variant infection in China: a retrospective cohort study
Lin Tang, Fuzhen Wang, Lance E. Rodewald, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 3, pp. 261-269
Open Access | Times Cited: 17
A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations
Lidan Hu, Jingmiao Sun, Yan Wang, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1045-1045
Open Access | Times Cited: 15
The MegaPool Approach to Characterize Adaptive CD4+ and CD8+ T Cell Responses
Ricardo da Silva Antunes, Daniela Weiskopf, John Sidney, et al.
Current Protocols (2023) Vol. 3, Iss. 11
Open Access | Times Cited: 15
New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic
Jonatan J. Carvajal, Valeria García-Castillo, Shelsy V. Cuellar, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Co-administration of recombinant BCG and SARS-CoV-2 proteins leads to robust antiviral immunity
Mario A. Ramírez, Ricardo A. Loaiza, Yohana Martínez-Balboa, et al.
Vaccine (2024) Vol. 42, Iss. 23, pp. 126203-126203
Closed Access | Times Cited: 2
Panorama of Breakthrough Infection Caused by SARS-CoV-2: A Review
Qinglu Fan, Zhihao Nie, Songping Xie
Medicina (2022) Vol. 58, Iss. 12, pp. 1733-1733
Open Access | Times Cited: 9
COVID-19 Vaccination in Pediatrics: Was It Valuable and Successful?
Mohamed Raslan, Sara A. Raslan, Eslam M. Shehata, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 214-214
Open Access | Times Cited: 5
Booster Vaccination with BNT162b2 Improves Cellular and Humoral Immune Response in the Pediatric Population Immunized with CoronaVac
Diego A. Díaz-Dinamarca, Simone Cardenas-Cáceres, Nicolás A. Muena, et al.
(2024)
Open Access | Times Cited: 1
Immunogenicity and safety of inactivated SARS-CoV-2 vaccine (CoronaVac) using two-dose primary protocol in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up
Camila Amormino Corsini, Priscila Fernanda da Silva Martins, Priscilla Soares Filgueiras, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Preclinical immunogenicity risk assessment of biotherapeutics using CD4 T cell assays
Robin E. Walsh, Angela Nix, Chloé Ackaert, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Comparative Immune Response after Vaccination with SOBERANA® 02 and SOBERANA® plus Heterologous Scheme and Natural Infection in Young Children
Rocmira Pérez-Nicado, Chiara Massa, Laura Rodríguez-Noda, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1636-1636
Open Access | Times Cited: 3
Immunogenicity of coronavirus disease 2019 vaccines in children: A review with ChatGPT
Daniel Leung, Jaime S. Rosa Duque, Wenwei Tu, et al.
Pediatric Discovery (2023) Vol. 1, Iss. 1
Open Access | Times Cited: 1
Statistical explanation of the protective effect of four COVID-19 vaccine doses in the general population
Humberto Reyes, Constanza Méndez, Alexis M. Kalergis
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 1
Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile
Nicole Le Corre, Katia Abarca, Patricio Astudillo, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1526-1526
Open Access | Times Cited: 1
Innate and Adaptive Cell-Mediated Immune Responses to a COVID-19 mRNA Vaccine in Young Children
Adriana Weinberg, Michael Johnson, Krystle Garth, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 12
Open Access | Times Cited: 1
Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents
Daniela Rivera-Pérez, Constanza Méndez, Benjamín Diethelm‐Varela, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Booster Vaccination with BNT162b2 Improves Cellular and Humoral Immune Response in the Pediatric Population Immunized with CoronaVac
Diego A. Díaz-Dinamarca, Simone Cardenas-Cáceres, Nicolás A. Muena, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 919-919
Open Access
HIV-1-Based SARS-CoV-2 Pseudotyped Virus to Determine Neutralizing Antibody Titers in Chile
Aracelly Gaete-Argel, Mónica L. Acevedo, Daniel R. Henríquez, et al.
˜The œLatin American studies book series (2024), pp. 225-238
Closed Access
Immunogenicity of the CoronaVac vaccine in children: a real-world study
Wbeimar Aguilar-Jiménez, Ana Lucia Rodríguez-Perea, Mateo Chvatal-Medina, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Page 1

Scroll to top